SM-26-017: Consumer and Consumer Support Technical Assistance Center
Closed
This grant is closed. A newer notice from the same program is forecast: GLS Campus Suicide Prevention (SM-27-001). Status: Forecast, no dates yet. It is in our archive of Substance Abuse and Mental Health Services Adminis notices from 2026.
Substance Abuse and Mental Health Services Adminis offered grants of up to $1.8 million to the applicants described in the notice. It expected to make one award worth $1.8 million in total. Applications closed on July 31, 2026.
From the official notice on Grants.gov, last changed July 7, 2026. Checked November 7, 2026.
- Award ceiling$1.8 million
- Total funding$1.8 million
- Expected awards1
- Cost sharingNot required
- Funding typeGrant
Key dates
| Posted | July 7, 2026 |
|---|---|
| Deadline | July 31, 2026 |
| Archived by Grants.gov | August 30, 2026 |
Who can apply
This opportunity was open to the applicants described in the notice.
- Others (see text field entitled "Additional Information on Eligibility" for clarification)
Eligibility is statutorily limited to domestic public and private non-profit entities.
Is this a realistic fit?
- No cost sharing or match is required.
What the grant funds
The purpose of this program is to establish and operate a national TAC dedicated to addressing priority mental health needs of regional and national significance. These activities can include: Developing, delivering, coordinating, and evaluating technical assistance to organizations that are dedicated to addressing mental health needs through courses, seminars, workshops, and cohort support to build skills and best practices to expand operational and program capacity. Strengthening the organizational readiness and sustainability of mental health PROs, Supporting peer workforce pathways and the innovative utilization of the peer workforce across service systems, including behavioral health care settings, physical health care settings, homelessness services, and community and justice-related settings, Integrating the peer workforce across all systems that serve individuals with SMI, including strengthening the readiness of non-behavioral health care providers to integrate peers. PROs play a critical role in supporting adults with lived experience of SMI, and Efforts to work with new types of partners that can reach new populations, including via faith-based and community-based organizations.
Applying now
This notice no longer takes applications. Apply under the newer notice, SM-27-001, which is forecast.
The notice on Grants.gov keeps its full text and attachments, which is useful for planning a resubmission.
Questions people ask
Is SM-26-017 still open?
No. It closed on July 31, 2026. A newer notice is forecast: SM-27-001, forecast, no dates yet.
Who can apply for Consumer and Consumer Support Technical Assistance Center?
Substance Abuse and Mental Health Services Adminis accepted applications from the applicants described in the notice. The notice adds further conditions, so read its eligibility section.
What is the deadline for Consumer and Consumer Support Technical Assistance Center?
Closed July 31, 2026. Applications are no longer accepted; the program's newer notices are on this page when there are any.
How much funding is available?
Awards of up to $1.8 million each. About $1.8 million in total for one award.
Similar open grants
- Single Source for the Continuation of the Caring for OutPatiEnts after Acute Kidney Injury (COPE-AKI) Scientific and Data Research Center (U01 Clinical Trial Required)
- Single Source for the Continuation of the Epidemiology of Diabetes Interventions and Complications (EDIC) Study Research Center (Collaborative U01 Clinical Trial Not Allowed)
- Data Coordinating Center for the Aging and Alzheimer’s Disease Mouse Brain Atlas (AD-MBA) (U24 Clinical Trial Not Allowed)
- Amyotrophic Lateral Sclerosis (ALS) Intermediate Patient Population Expanded Access (U01 Clinical Trial Required)
- Advanced Development and Validation of Emerging Technologies for Basic and Clinical Cancer Research (R33 Clinical Trial Not Allowed)
- Early-Stage Innovative Technology Development for Basic and Clinical Cancer Research (R61 Clinical Trial Not Allowed)